RTI International

• NCT06855108

  Collaborator, Phase 3, Recruiting, 830 people, 3 Mar 2025

• NCT05898022

  Collaborator, Phase 4, Completed, 19 people, 12 Jun 2023

• Nutrition for Precision Health, Powered by the All of Us

  Recruiting, 8,000 people, 27 Jan 2023

• NCT04987775

  Collaborator, Early phase 1, Recruiting, 170 people, 3 Aug 2021

• NCT03122691

  Collaborator, Phase 1, Completed, 23 people, 21 Apr 2017

• NCT02165176

  Collaborator, Phase 1, Completed, 24 people, 17 Jun 2014

• NCT01798186

  Collaborator, Phase 1, Completed, 26 people, 25 Feb 2013

• NCT01389024

  Collaborator, Phase 2, Completed, 28 people, 7 Jul 2011

• NCT01329016

  Collaborator, Phase 1/2, Completed, 177 people, 5 Apr 2011

• NCT00098319

  Collaborator, Phase 3, Completed, 2,200 people, 7 Dec 2004

• NCT00098202

  Collaborator, Phase 3, Completed, 420 people, 6 Dec 2004

• NCT00097110

  Collaborator, Phase 3, Completed, 734 people, 18 Nov 2004

Sources: clinicaltrials.gov

• Economic evaluation of NT-proBNP testing plus standard clinical assessment versus standard clinical assessment alone for the prevention of heart failure in older adults with type 2 diabetes

  Employment, 28 Sept 2026

Sources: pubmed.ncbi.nlm.nih.gov

• Lipid Profiles as Independent Predictors of Glycemic Control

  ADA Scientific Sessions 2026 abstract, 5 Jun 2026

• Long-Term Cost-Effectiveness of Using Glucagon-Like Peptide 1 Receptor Agonists (GLP-1RAs) for Preventing Type 2 Diabetes (T2D) in U.S. Adults with Prediabetes and Obesity—A Simulation Study

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025